Cancer researchers highlighted several treatment breakthroughs during their annual summit in Chicago that concluded Tuesday, including preliminary but encouraging data on

Jonathan Cohn talks with oncologist and UPenn vice provost Zeke Emanuel about the breakthrough new pancreatic cancer treatment—what the science actually means, why it took so long, and what Trump’s cuts to federal research funding put at risk.

A new drug for six common cancers shrank previously untreatable tumours in a trial involving patients with advanced cancer. The daily pill works by unmasking tumours hiding from the immune system.

A new once-daily targeted therapy, daraxonrasib, has nearly doubled survival in patients with advanced pancreatic cancer in a landmark Phase 3 trial. Experts are calling it one of the most significant breakthroughs against one of the world's deadliest cancers in decades.